These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

306 related articles for article (PubMed ID: 25981364)

  • 1. Rivaroxaban-induced liver injury: Results from a venous thromboembolism registry.
    Lambert A; Cordeanu M; Gaertner S; Nouri S; Alt M; Stephan D
    Int J Cardiol; 2015 Jul; 191():265-6. PubMed ID: 25981364
    [No Abstract]   [Full Text] [Related]  

  • 2. Efficacy and Safety of Rivaroxaban in Patients with Venous Thromboembolism and Active Malignancy: A Single-Center Registry.
    Bott-Kitslaar DM; Saadiq RA; McBane RD; Loprinzi CL; Ashrani AA; Ransone TR; Wolfgram AA; Berentsen MM; Wysokinski WE
    Am J Med; 2016 Jun; 129(6):615-9. PubMed ID: 26797081
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Rivaroxaban as monotherapy in patients with venous thromboembolism].
    Krivoshchekov EP; Migunov IA; Romanov VE
    Khirurgiia (Mosk); 2016; (10):61-65. PubMed ID: 27804937
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rivaroxaban for the treatment of venous thromboembolism. The SWIss Venous ThromboEmbolism Registry (SWIVTER).
    Kucher N; Aujesky D; Beer JH; Mazzolai L; Baldi T; Banyai M; Hayoz D; Kaeslin T; Korte W; Escher R; Husmann M; Frauchiger B; Baumgartner I; Spirk D
    Thromb Haemost; 2016 Aug; 116(3):472-9. PubMed ID: 27346301
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of gender on safety and efficacy of Rivaroxaban in adolescents & young adults with venous thromboembolism.
    Krause M; Henningsen A; Torge A; Juhl D; Junker R; Kenet G; Kowalski D; Limperger V; Mesters R; Anonymous ; Rocke A; Shneyder M; Clausnizer H; Schiesewitz H; Nowak-Göttl U
    Thromb Res; 2016 Dec; 148():145-151. PubMed ID: 27687905
    [No Abstract]   [Full Text] [Related]  

  • 6. Effect of extremes of body weight on drug level in patient treated with standard dose of rivaroxaban for venous thromboembolism; real life experience.
    Arachchillage D; Reynolds R; Devey T; Maclean R; Kitchen S; van Veen JJ
    Thromb Res; 2016 Nov; 147():32-35. PubMed ID: 27669125
    [No Abstract]   [Full Text] [Related]  

  • 7. Rivaroxaban for the treatment of venous thromboembolism. A "real-life" perspective in 103 patients.
    Jara-Palomares L; Sanchez-Oro-Gomez R; Elias-Hernandez T; Morillo-Guerrero R; Ferrer-Galvan M; Asensio-Cruz MI; Barrot-Cortes E; Otero-Candelera R
    Thromb Res; 2014 Sep; 134(3):617-21. PubMed ID: 25034320
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recurrent Venous Thromboembolism in Two Patients With Cancer Taking Rivaroxaban.
    Theodorou JM; Patel Y; Ford P
    J Pharm Pract; 2017 Jun; 30(3):381-384. PubMed ID: 27026636
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rivaroxaban: liver injury.
    Prescrire Int; 2015 Nov; 24(165):268. PubMed ID: 26688900
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of Rivaroxaban Therapy on ROTEM Coagulation Parameters in Patients with Venous Thromboembolism.
    Chojnowski K; Górski T; Robak M; Treliński J
    Adv Clin Exp Med; 2015; 24(6):995-1000. PubMed ID: 26771971
    [TBL] [Abstract][Full Text] [Related]  

  • 11. "Effect of polypharmacy on bleeding with rivaroxaban versus vitamin K antagonist for treatment of venous thromboembolism": Comment.
    Lijfering WM
    J Thromb Haemost; 2022 Jul; 20(7):1747. PubMed ID: 35754012
    [No Abstract]   [Full Text] [Related]  

  • 12. "Effect of polypharmacy on bleeding with rivaroxaban versus vitamin K antagonist for treatment of venous thromboembolism": Reply.
    Bistervels IM; Bavalia R; Middeldorp S; Coppens M
    J Thromb Haemost; 2022 Jul; 20(7):1748-1749. PubMed ID: 35754011
    [No Abstract]   [Full Text] [Related]  

  • 13. Rivaroxaban induced liver injury: A cholestatic pattern.
    Cordeanu M; Gaertner S; Bensalah N; Mirea C; Hamade A; Stephan D
    Int J Cardiol; 2016 Aug; 216():97-8. PubMed ID: 27140342
    [No Abstract]   [Full Text] [Related]  

  • 14. Utility of Rivaroxaban for Real-World Patients With Venous Thromboembolism.
    Yamashita Y
    Circ J; 2023 Aug; 87(9):1185-1186. PubMed ID: 37225452
    [No Abstract]   [Full Text] [Related]  

  • 15. A Case of Cerebral Infarction During Treatment With Rivaroxaban for Venous Thromboembolism.
    Kitahara K; Momo K; Nimura S; Okazaki K; Suzuki N; Kubota Y; Tsunoda T; Watanabe D; Mizuma K; Ono K; Sasaki T
    Am J Ther; 2022 Nov-Dec 01; 29(6):e673-e676. PubMed ID: 33395052
    [No Abstract]   [Full Text] [Related]  

  • 16. Delayed-onset heparin-induced thrombocytopenia without thrombosis in a patient receiving postoperative thromboprophylaxis with rivaroxaban.
    Tardy-Poncet B; Piot M; Montmartin A; Burdier A; Chalayer E; Tardy B
    Thromb Haemost; 2015 Aug; 114(3):652-4. PubMed ID: 26062524
    [No Abstract]   [Full Text] [Related]  

  • 17. [Hemoptysis during concomitant treatment with rivaroxaban and amiodarone in a patient with a history of pulmonary disease].
    Elikowski W; Małek M; Skowroński M; Wróblewski D; Skrzywanek P; Zawilska K
    Pol Merkur Lekarski; 2015 Oct; 39(232):227-30. PubMed ID: 26608490
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rivaroxaban use in patients with antiphospholipid syndrome and previous venous thromboembolism.
    Sciascia S; Breen K; Hunt BJ
    Blood Coagul Fibrinolysis; 2015 Jun; 26(4):476-7. PubMed ID: 25923780
    [No Abstract]   [Full Text] [Related]  

  • 19. Single-Dose Rivaroxaban-Induced Acute Liver Injury.
    Verheyen E; Kileci JA; Mathew JP
    Am J Ther; 2019; 26(4):e538-e540. PubMed ID: 29889676
    [No Abstract]   [Full Text] [Related]  

  • 20. Retrospective Evaluation of Postoperative Bleeding Events in Patients Receiving Rivaroxaban After Undergoing Total Hip and Total Knee Arthroplasty: Comparison with Clinical Trial Data.
    Wood RC; Stewart DW; Slusher L; El-Bazouni H; Cluck D; Freshour J; Odle B
    Pharmacotherapy; 2015 Jul; 35(7):663-9. PubMed ID: 26095331
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.